Skip to main content
. 2021 Nov 11;12:721819. doi: 10.3389/fphar.2021.721819

FIGURE 5.

FIGURE 5

Simulations of the 1,000-mg q12h dose for patients with different renal status (A) and simulation of tailored dose based on the renal status of the patients (B).